PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
GTCbio

Press Release


Receive press releases from GTCbio: By Email RSS Feeds:

Barbara Wirostko, Senior Medical Director, Team Lead Ophthalmology, Pfizer to Speak at 2nd Annual Ocular Disease Drug & Discovery Conference


Barbara Wirostko, Senior Medical Director, Team Lead Ophthalmology, Pfizer will give a presentation at GTCbios 2nd Annual Ocular Disease Drug & Discovery Conference, May 27 28, 2010 in Boston, MA.

Monrovia, CA, March 13, 2010 --(PR.com)-- Barbara Wirostko, Senior Medical Director, Team Lead Ophthalmology, Pfizer will present on Endothelin: A Potential Novel Mechanism for Future Drug Development in Ophthalmology at GTCbio’s 2nd Annual Ocular Disease Drug & Discovery Conference on May 27 – 28, 2010 in Boston, MA.

Barbara Wirostko will present her topic on Endothelin as a novel target. The benefits of the talk will cover the background and supporting data that exists to support this as a novel MOA and target, the rationale from a pathophysiologic perspective, the impact that modulating this target could have on ocular disease and pathology, and the clinical rationale for why such a novel approach is necessary.

GTCbio’s Ocular Disease conference will also bring together leading academics from Harvard, Columbia University, National Eye Institute as well as Industries from Pfizer, GlaxoSmithKline, and Genzyme. Updates on the age related macular degeneration, recent drug developments & mechanisms, ocular disease, and future of ocular disease therapeutics will be addressed and discussed.

GTCbio’s 2nd annual conference on Ocular Disease Drug and Discovery will provide cutting edge information and a chance to exchange ideas from leading experts in the field. Don’t miss this opportunity to register for GTCbio’s 2nd Annual Ocular Disease Drug and Discovery conference. Please check their website for the most up to date information: http://www.gtcbio.com/conferenceDetails.aspx?id=148

###
Contact Information
GTCbio
David Stoops
626-256-6405
Contact
http://www.gtcbio.com
GTCbio, 434 W. Foothill Blvd. Monrovia, CA 91016 fax: (626) 256-6460 email: infogtcbio@gtcbio.com

Click here to view the list of recent Press Releases from GTCbio
Promote Your Business